Basis: Current FMP quote-based enterprise value / four-quarter operating cash flow less absolute capital expenditures. Source: stored company filings and market data; unavailable inputs remain N/A.
The EV/FCF ratio is N/A as of 2026-10-06T21:30:51.661Z.
Calculation as of: 2026-10-06T21:30:51.661Z.
Quote observation: 2026-10-06T20:00:01.000Z. Amounts in USD. The price header may show a later quote.
FMP input reference: 09d62e22afa0eb1a5da77a5c6bfdaaeedfdfba09b979310b40e193a87c10cfd4
Historical values estimate market capitalization from statement-period weighted shares. Comparisons with the current quote-based value are approximate. Only filing versions delivered by FMP are available for the historical calculation. Historical series through 2024-08-05.
Historical values estimate market capitalization from statement-period weighted shares. Comparisons with the current quote-based value are approximate. Only filing versions delivered by FMP are available for the historical calculation.
EV/FCF RATIO
N/A
EV/FCF RATIO AVG TTM
14.66x
EV/FCF RATIO AVG 3Y
N/A
EV/FCF RATIO AVG 5Y
N/A
EV/FCF RATIO AVG 10Y
N/A
EV/FCF RATIO AVG 15Y
N/A
EV/FCF RATIO AVG 20Y
N/A
CURRENT VS TTM AVG
N/A
CURRENT VS 3Y AVG
N/A
CURRENT VS 5Y AVG
N/A
CURRENT VS 10Y AVG
N/A
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
Arcturus Therapeutics Holdings Inc.
Market Cap
$369.50M
EV/FCF Ratio
N/A
TTM Avg
14.66x
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$359.53M
EV/FCF Ratio
N/A
TTM Avg
6.23x
3Y Avg
6.23x
5Y Avg
6.23x
Market Cap
$380.37M
EV/FCF Ratio
N/A
TTM Avg
1559.86x
3Y Avg
1559.86x
5Y Avg
273.86x
Market Cap
$355.43M
EV/FCF Ratio
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$355.36M
EV/FCF Ratio
12.19x
TTM Avg
33.56x
3Y Avg
51.03x
5Y Avg
195.24x
| NAME | MARKET CAP | EV/FCF RATIO | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Arcturus Therapeutics Holdings Inc. (ARCT) | $369.50M | N/A | 14.66x | N/A | N/A |
| Kyverna Therapeutics, Inc. (KYTX)vs › | $374.50M | N/A | N/A | N/A | N/A |
| Canopy Growth Corporation (CGC)vs › | $376.01M | N/A | N/A | N/A | N/A |
| Zura Bio Limited (ZURA)vs › | $376.19M | N/A | N/A | N/A | N/A |
| Opus Genetics, Inc. (IRD)vs › | $361.64M | N/A | N/A | N/A | N/A |
| Fennec Pharmaceuticals Inc. (FENC)vs › | $359.53M | N/A | 6.23x | 6.23x | 6.23x |
| Orthofix Medical Inc. (OFIX)vs › | $380.37M | N/A | 1559.86x | 1559.86x | 273.86x |
| Artiva Biotherapeutics, Inc. (ARTV)vs › | $355.43M | N/A | N/A | N/A | N/A |
| Viemed Healthcare, Inc. (VMD)vs › | $355.36M | 12.19x | 33.56x | 51.03x | 195.24x |
| Enanta Pharmaceuticals, Inc. (ENTA)vs › | $353.88M | N/A | 50.02x | 37.43x | 35.40x |
EV/FCF
N/A
P/FCF
N/A
FCF Yield
N/A
Formula: EV/FCF = Enterprise Value / Free Cash Flow
EV/FCF vs P/FCF:
EV/FCF = Enterprise Value / Free Cash Flow (TTM)
Enterprise value to free cash flow compares total company value to the cash the business generates after capital expenditures.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | EV/FCF RATIO |
|---|---|
| 2024-08-05 | 28.21x |
| 2024-08-02 | 30.30x |
| 2024-08-01 | 33.14x |
| 2024-07-31 | 38.31x |
| 2024-07-30 | 38.01x |
| 2024-07-29 | 39.63x |
| 2024-07-26 | 39.99x |
| 2024-07-25 | 36.99x |
| 2024-07-24 | 35.34x |
| 2024-07-23 | 38.75x |
| 2024-07-22 | 39.47x |
| 2024-07-19 | 39.22x |
| 2024-07-18 | 38.20x |
| 2024-07-17 | 40.57x |
| 2024-07-16 | 43.60x |
| 2024-07-15 | 38.09x |
| 2024-07-12 | 37.49x |
| 2024-07-11 | 39.14x |
| 2024-07-10 | 33.55x |
| 2024-07-09 | 35.61x |
| 2024-07-08 | 33.11x |
| 2024-07-05 | 32.78x |
| 2024-07-03 | 34.10x |
| 2024-07-02 | 32.86x |
| 2024-07-01 | 38.86x |
| 2024-06-28 | 40.76x |
| 2024-06-27 | 41.04x |
| 2024-06-26 | 41.12x |
| 2024-06-25 | 46.05x |
| 2024-06-24 | 48.96x |
| 2024-06-21 | 49.29x |
| 2024-06-20 | 46.93x |
| 2024-06-18 | 45.19x |
| 2024-06-17 | 51.17x |
| 2024-06-14 | 59.07x |
| 2024-06-13 | 60.72x |
| 2024-06-12 | 59.23x |
| 2024-06-11 | 62.81x |
| 2024-06-10 | 61.52x |
| 2024-06-07 | 61.32x |
| 2024-06-06 | 91.00x |
| 2024-06-05 | 95.92x |
| 2024-06-04 | 87.75x |
| 2024-06-03 | 85.66x |
| 2024-05-31 | 80.56x |
| 2024-05-30 | 79.65x |
| 2024-05-29 | 74.81x |
| 2024-05-28 | 79.46x |
| 2024-05-24 | 57.44x |
| 2024-05-23 | 59.64x |
| 2024-05-22 | 62.86x |
| 2024-05-21 | 55.90x |
| 2024-05-20 | 57.69x |
| 2024-05-17 | 55.71x |
| 2024-05-16 | 57.69x |
| 2024-05-15 | 53.62x |
| 2024-05-14 | 55.60x |
| 2024-05-13 | 52.79x |
| 2024-05-10 | 48.77x |
| 2024-05-09 | 47.48x |
| 2024-03-14 | 5.15x |
| 2024-03-13 | 5.45x |
| 2024-03-12 | 5.60x |
| 2024-03-11 | 5.45x |
| 2024-03-08 | 5.25x |
| 2024-03-07 | 5.31x |
| 2024-03-06 | 5.43x |
| 2024-03-05 | 5.38x |
| 2024-03-04 | 5.40x |
| 2024-03-01 | 5.81x |
| 2024-02-29 | 5.62x |
| 2024-02-28 | 5.89x |
| 2024-02-27 | 6.44x |
| 2024-02-26 | 6.04x |
| 2024-02-23 | 5.36x |
| 2024-02-22 | 5.36x |
| 2024-02-21 | 4.94x |
| 2024-02-20 | 5.12x |
| 2024-02-16 | 5.26x |
| 2024-02-15 | 5.51x |
| 2024-02-14 | 5.56x |
| 2024-02-13 | 5.62x |
| 2024-02-12 | 6.17x |
| 2024-02-09 | 5.79x |
| 2024-02-08 | 5.45x |
| 2024-02-07 | 5.33x |
| 2024-02-06 | 5.42x |
| 2024-02-05 | 4.90x |
| 2024-02-02 | 4.83x |
| 2024-02-01 | 4.82x |
| 2024-01-31 | 4.49x |
| 2024-01-30 | 4.44x |
| 2024-01-29 | 4.62x |
| 2024-01-26 | 4.25x |
| 2024-01-25 | 4.48x |
| 2024-01-24 | 4.34x |
| 2024-01-23 | 4.82x |
| 2024-01-22 | 4.72x |
| 2024-01-19 | 4.45x |
| 2024-01-18 | 4.36x |
| 2024-01-17 | 4.39x |
| 2024-01-16 | 4.36x |
| 2024-01-12 | 4.53x |
| 2024-01-11 | 4.31x |
| 2024-01-10 | 4.73x |
| 2024-01-09 | 4.49x |
| 2024-01-08 | 4.43x |
| 2024-01-05 | 4.16x |
| 2024-01-04 | 4.17x |
| 2024-01-03 | 4.18x |
| 2024-01-02 | 4.52x |
| 2023-12-29 | 4.21x |
| 2023-12-28 | 4.49x |
| 2023-12-27 | 4.45x |
| 2023-12-26 | 4.46x |
| 2023-12-22 | 4.25x |
| 2023-12-21 | 4.17x |
| 2023-12-20 | 4.07x |
| 2023-12-19 | 4.39x |
| 2023-12-18 | 3.66x |
| 2023-12-15 | 3.70x |
| 2023-12-14 | 3.54x |
| 2023-12-13 | 3.13x |
| 2023-12-12 | 2.63x |
| 2023-12-11 | 2.63x |
| 2023-12-08 | 2.71x |
| 2023-12-07 | 2.76x |
| 2023-12-06 | 2.64x |
| 2023-12-05 | 2.55x |
| 2023-12-04 | 2.75x |
| 2023-12-01 | 2.92x |
| 2023-11-30 | 2.74x |
| 2023-11-29 | 2.80x |
| 2023-11-28 | 3.05x |
| 2023-11-27 | 3.10x |
| 2023-11-24 | 2.74x |
| 2023-11-22 | 2.66x |
| 2023-11-21 | 2.55x |
| 2023-11-20 | 2.83x |
| 2023-11-17 | 2.95x |
| 2023-11-16 | 2.40x |
| 2023-11-15 | 2.47x |
| 2023-11-14 | 1.86x |
| 2023-11-13 | 1.53x |
| 2023-11-10 | 1.81x |
| 2023-11-09 | 1.76x |
| 2023-11-08 | 1.86x |
| 2023-11-07 | 1.90x |
| 2023-11-06 | 1.67x |
| 2023-11-03 | 1.90x |
| 2023-11-02 | 1.71x |
| 2023-11-01 | 1.74x |
| 2023-10-31 | 1.80x |
| 2023-10-30 | 1.72x |
| 2023-10-27 | 1.67x |
| 2023-10-26 | 1.83x |
| 2023-10-25 | 1.77x |
| 2023-10-24 | 1.95x |
| 2023-10-23 | 1.85x |
| 2023-10-20 | 2.01x |
| 2023-10-19 | 2.09x |
| 2023-10-18 | 2.25x |
| 2023-10-17 | 2.46x |
| 2023-10-16 | 2.49x |
| 2023-10-13 | 2.54x |
| 2023-10-12 | 2.63x |
| 2023-10-11 | 2.78x |
| 2023-10-10 | 2.91x |
| 2023-10-09 | 2.85x |
| 2023-10-06 | 2.97x |
| 2023-10-05 | 3.03x |
| 2023-10-04 | 2.97x |
| 2023-10-03 | 2.85x |
| 2023-10-02 | 3.08x |
| 2023-09-29 | 3.08x |
| 2023-09-28 | 3.06x |
| 2023-09-27 | 3.43x |
| 2023-09-26 | 3.33x |
| 2023-09-25 | 3.23x |
| 2023-09-22 | 3.44x |
| 2023-09-21 | 3.37x |
| 2023-09-20 | 3.28x |
| 2023-09-19 | 3.57x |
| 2023-09-18 | 3.41x |
| 2023-09-15 | 3.71x |
| 2023-09-14 | 3.89x |
| 2023-09-13 | 3.85x |
| 2023-09-12 | 4.11x |
| 2023-09-11 | 4.34x |
| 2023-09-08 | 4.35x |
| 2023-09-07 | 4.23x |
| 2023-09-06 | 4.46x |
| 2023-09-05 | 4.24x |
| 2023-09-01 | 4.39x |
| 2023-08-31 | 4.09x |
| 2023-08-30 | 4.34x |
| 2023-08-29 | 4.37x |
| 2023-08-28 | 4.35x |
| 2023-08-25 | 4.32x |
| 2023-08-24 | 4.20x |
| 2023-08-23 | 4.58x |
| 2023-08-22 | 4.57x |
| 2023-08-21 | 4.26x |
| 2023-08-18 | 3.93x |
| 2023-08-17 | 3.60x |
| 2023-08-16 | 3.63x |
| 2023-08-15 | 4.01x |
| 2023-08-14 | 3.92x |
| 2023-08-11 | 3.55x |
| 2023-08-10 | 3.87x |
| 2023-08-09 | 3.69x |
| 2023-08-08 | 3.12x |
| 2023-08-07 | 14.96x |
| 2023-08-04 | 15.17x |
| 2023-08-03 | 15.61x |
| 2023-08-02 | 16.59x |
| 2023-08-01 | 17.15x |
| 2023-07-31 | 17.18x |
| 2023-07-28 | 16.73x |
| 2023-07-27 | 16.14x |
| 2023-07-26 | 17.01x |
| 2023-07-25 | 18.20x |
| 2023-07-24 | 17.67x |
| 2023-07-21 | 16.38x |
| 2023-07-20 | 16.63x |
| 2023-07-19 | 17.56x |
| 2023-07-18 | 18.88x |
| 2023-07-17 | 18.38x |
| 2023-07-14 | 17.52x |
| 2023-07-13 | 14.22x |
| 2023-07-12 | 14.35x |
| 2023-07-11 | 13.83x |
| 2023-07-10 | 14.55x |
| 2023-07-07 | 13.18x |
| 2023-07-06 | 12.99x |
| 2023-07-05 | 12.47x |
| 2023-07-03 | 12.69x |
| 2023-06-30 | 12.70x |
| 2023-06-29 | 11.20x |
| 2023-06-28 | 10.78x |
| 2023-06-27 | 10.01x |
| 2023-06-26 | 9.80x |
| 2023-06-23 | 9.32x |
| 2023-06-22 | 9.81x |
| 2023-06-21 | 10.09x |
| 2023-06-20 | 10.86x |
| 2023-06-16 | 10.93x |
| 2023-06-15 | 11.85x |
| 2023-06-14 | 11.95x |
| 2023-06-13 | 12.73x |
| 2023-06-12 | 11.80x |
| 2023-06-09 | 11.85x |
| 2023-06-08 | 12.49x |
| 2023-06-07 | 12.56x |
| 2023-06-06 | 11.33x |
| 2023-06-05 | 11.48x |
| 2023-06-02 | 11.42x |
| 2023-06-01 | 11.55x |
| 2023-05-31 | 11.75x |
| 2023-05-30 | 11.22x |
Showing the most recent 260 of 302 data points. The chart above shows the full history.
